Company Grown Rogue International Inc.

GRIN

CA39986R3045

Pharmaceuticals

Delayed Canadian Securities Exchange 09:35:58 2026-08-12 EDT			5-day change	1st Jan Change
0.6500 ^CAD	+3.17%		+10.17%	-7.14%

08-05	Earnings Flash (GRIN.CN) Grown Rogue International Reports Q2 Revenue $11.3M	MT
08-04	Grown Rogue International Inc., Q2 2026 Earnings Call, Aug 04, 2026

Business description: Grown Rogue International Inc.

Grown Rogue International Inc. is a craft cannabis company operating in Oregon, Michigan, and New Jersey and under development in Illinois. The Company is focused on providing customers with premium flower and flower-derived products. Through its subsidiary, Grown Rogue Gardens, LLC, it operates four cultivation facilities in Oregon, comprising over 95,000 square feet of flowering cultivation canopy, that service the Oregon recreational marijuana market: two outdoor, sungrown farms called Foothill and Ross Lane, and two indoor facilities. Its subsidiary, Canopy Management, LLC, operates a Golden Harvests facility that produces indoor flowers through controlled environment agriculture, with 14 individual flowering rooms in operation. It produces a range of cultivars for consumers, which are traditionally classified as indicas, sativas, and hybrids. It offers nitrogen sealed 3.5-gram flower jars, patented nitrogen sealed pre-rolls, 3.5-gram flower bags and regularly packaged pre-rolls.

Sales by Activity: Grown Rogue International Inc.

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
New Jersey	-	-	-	-	11.34M
Oregon	-	-	11M	12.09M	11.06M
Michigan	-	-	11.42M	12.94M	10.03M
Corporate	-	-	929K	1.99M	-
Pharmaceuticals	9.38M	17.76M	-	-	-

See all business segments

Geographical breakdown of sales: Grown Rogue International Inc.

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
United States	9.38M	17.76M	23.35M	27.02M	32.43M

See all geographic segments

Executive Committee: Grown Rogue International Inc.

Manager	Title	Age	Since
J. Strickler CEO	Chief Executive Officer	45	2018-11-14
Sarah Strickler PRN	Corporate Officer/Principal	-	2016-09-30
Andrew Marchington DFI	Director of Finance/CFO	42	2024-12-31
Joshua Rosen PRN	Corporate Officer/Principal	53	2025-01-30

See GROWN ROGUE INTERNATIONAL INC. governance

Composition of the Board of Directors: Grown Rogue International Inc.

Director	Title	Age	Since
Stephen Gledhill BRD	Director/Board Member	64	2018-11-14
J. Strickler BRD	Director/Board Member	45	2018-11-14
Ryan Kee BRD	Director/Board Member	42	-
Sean Conacher BRD	Director/Board Member	55	2020-08-26

Composition of the Board of Directors

Shareholders: Grown Rogue International Inc.

Name	Stocks	%	Valuation
J. Strickler 15.36 %	38,401,399	15.36 %	16 M $
Mindset Capital LLC 14.93 %	37,311,733	14.93 %	16 M $
Bengal Catalyst Fund LP 8.57 %	21,420,100	8.57 %	9 M $
Ryan Kee 0.528 %	1,319,583	0.528 %	556 864 $
Sean Conacher 0.3876 %	968,850	0.3876 %	408 855 $

List of GROWN ROGUE INTERNATIONAL INC. shareholders

Company details: Grown Rogue International Inc.

Grown Rogue International, Inc.

550 Airport Road

97504, Medford

http://www.grownrogue.com

address Grown Rogue International Inc.(GRIN)

Alternative Medicine

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
GROWN ROGUE INTERNATIONAL INC.	+3.17%	+10.17%	+1.56%	+154.90%	113M
YUNNAN BAIYAO GROUP CO.,LTD	-0.70%	-1.68%	-9.25%	-6.56%	13.44B
DONG-E-E-JIAO CO., LTD.	-0.81%	-1.79%	+4.58%	+3.87%	5.07B
BEIJING TONGRENTANG CO., LTD	-0.99%	-3.41%	-32.01%	-56.10%	5.06B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-0.12%	+0.48%	+4.20%	-30.78%	4.18B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-1.13%	-2.70%	-13.13%	-5.79%	3.66B
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.	-0.93%	-2.77%	-3.64%	+2.27%	3.5B
TASLY PHARMACEUTICAL GROUP CO., LTD	-0.64%	-2.02%	-4.55%	+16.50%	3.44B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-0.44%	0.00%	-13.66%	-16.09%	2.47B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+0.71%	-1.18%	-2.89%	+42.72%	1.88B
Average	-0.19%	+0.57%	-6.88%	+10.50%	4.28B
Weighted average by Cap.	-0.65%	-0.32%	-8.43%	-8.86%